Development of high-efficiency molecular adsorbent recirculating system: Preliminary report

Artificial Organs

Volumn 38, Issue 10, 2014, Pages 879-883

  Marangoni, Roberto ^a   Bellati, Giorgio ^a   Castelli, Alessandro ^b   Romagnoli, Elisabetta ^b  

^a SANT ANNA HOSPITAL   (Italy)

^b Gepa srl   (Italy)

Author keywords

Adsorption units; High efficiency molecular adsorbent recirculating system; Liver failure

Indexed keywords

BODY FLUIDS; PATIENT TREATMENT;

% REDUCTIONS; ADSORPTION UNIT; BILE ACID; HIGH-EFFICIENCY MOLECULAR ADSORBENT RECIRCULATING SYSTEM; HIGHER EFFICIENCY; LIVER FAILURE; RECIRCULATING SYSTEM; SERUM BILIRUBIN; SUPPORT SYSTEMS;

EFFICIENCY;

BILE ACID; BILIRUBIN;

ADULT; AGED; ALBUMIN DIALYSIS; ARTICLE; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CLINICAL EFFECTIVENESS; DIALYZER; FEMALE; HUMAN; LIVER FAILURE; LIVER SUPPORT; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; OUTCOME ASSESSMENT; BLOOD; DETOXIFICATION; EXTRACORPOREAL CIRCULATION; LIVER; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME;

BILIRUBIN; EXTRACORPOREAL CIRCULATION; HUMANS; LIVER; LIVER FAILURE; MALE; MIDDLE AGED; SORPTION DETOXIFICATION; TREATMENT OUTCOME;

EID: 84916235145     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12250     Document Type: Article

References (11)

1. Mitzner SR, Stange J, Klammt S, etal. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS. Results of a prospective randomized, controlled clinical trial. Liver Transpl 2000;6:277-286.
2. Heeman U, Treichel U, Loock J, etal. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective controlled study. Hepatology 2002;36:949-958.
3. Saliba F, Camus C, Durand F, etal. Randomized controlled multicenter trial evaluating the efficacy and safety of albumin dialysis with MARS in patients with fulminant and subfulminant hepatic failure. The Liver Meeting 2008, 50th anniversary meeting of the International Association for the Study of Liver, San Francisco 2008. Hepatology 2008;48(4 Suppl.).
4. Mitzner SR. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS). Ann Hepatol 2011;10:S21-28.
5. Schmidt L, Wang L, Hansen B, Larsen F. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 2003;9:290-297.
6. Laleman W, Wilmer A, Evenepoel P, etal. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006;10:R108, 1-28.
7. Sen S, Mookerjee RP, Cheshire LM, Davies NA, Williams R, Jalan R. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J Hepatol 2005;43:142-148.
8. Banares R, Nevens F, Stolze Larsen F, etal. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 2013;57:1153-1162.
9. Krisper P, Hadisch B, Stauber R, etal. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005;43:451-457.
10. Evenpoel P, Laleman W, Wilmer A, etal. Prometheus versus Molecular Adsorbent Recirculating System: comparison of efficiency of two different liver detoxification devices. Artif Organs 2006;30:276-284.
11. Stadlbauer V, Krisper P, Beuers U, etal. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. ASAIO J 2007;53:187-193.